- Report
- October 2024
- 186 Pages
Global
From €3245EUR$3,545USD£2,758GBP
€3606EUR$3,939USD£3,064GBP
- Report
- March 2025
- 144 Pages
Global
From €2745EUR$2,999USD£2,333GBP
- Report
- April 2025
- 307 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- April 2025
- 200 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- April 2025
- 200 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- February 2025
- 200 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- February 2025
- 200 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- March 2025
- 180 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- July 2024
- 100 Pages
Global
From €3433EUR$3,750USD£2,917GBP
- Report
- January 2022
- 120 Pages
Global
From €4348EUR$4,750USD£3,695GBP
- Report
- May 2024
- 200 Pages
Global
From €3799EUR$4,150USD£3,229GBP
- Report
- February 2024
- 185 Pages
North America
From €3158EUR$3,450USD£2,684GBP
- Report
- October 2023
- 146 Pages
Africa, Middle East
From €3158EUR$3,450USD£2,684GBP
- Report
- October 2023
- 145 Pages
From €3158EUR$3,450USD£2,684GBP
- Report
- July 2023
- 198 Pages
Europe
From €3158EUR$3,450USD£2,684GBP
- Report
- June 2023
- 184 Pages
Asia Pacific
From €3158EUR$3,450USD£2,684GBP
- Report
- March 2023
- 185 Pages
Global
From €4074EUR$4,450USD£3,462GBP
- Report
- May 2023
- 147 Pages
Global
From €4530EUR$4,949USD£3,850GBP
- Report
- February 2024
- 94 Pages
Global
From €3500EUR$4,096USD£3,079GBP
- Report
- May 2025
- 50 Pages
Global
From €2426EUR$2,650USD£2,062GBP

Yttrium-90 is a radioactive isotope used in Nuclear Medicine and Radiopharmacology. It is used in the treatment of cancer, as well as other diseases, and is produced in nuclear reactors. Yttrium-90 is used in a variety of medical applications, including targeted radiotherapy, radioembolization, and radioimmunotherapy. It is also used in the diagnosis of certain diseases, such as liver cancer.
Yttrium-90 is produced in a variety of forms, including microspheres, nanospheres, and liquid formulations. It is also available in a variety of formulations, including capsules, tablets, and injectables.
The Yttrium-90 market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include Nordion, Eckert & Ziegler, IBA Molecular, and Advanced Accelerator Applications. Show Less Read more